Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions

CompletedOBSERVATIONAL
Enrollment

754

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Coronary Artery DiseaseCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases
Interventions
PROCEDURE

CorPath-assisted Percutaneous Coronary Intervention

Robotic-assisted Percutaneous Coronary Intervention

Trial Locations (16)

10032

Columbia University Medical Center/New York-Presbyterian Hospital, New York

13203

St. Joseph's Hospital Health Center, Syracuse

20010

Medstar Washington Hospital Center, Washington D.C.

22908

University of Virginia, Charlottesville

23298

Virginia Commonwealth Univ. Medical Center, Richmond

28203

Carolinas Medical Center - Northeast, Concord

30501

North Georgia Heart Foundation, Gainesville

32806

Orlando Regional Medical Center, Orlando

44106

University Hospitals Case Medical Center, Cleveland

49503

Spectrum Health System, Grand Rapids

55906

Mayo Clinic, Rochester

57104

Sanford Health, Sioux Falls

81601

Valley View Hospital, Glenwood Springs

91031

Shaare Zedek Medical Center, Jerusalem

92103

UC San Diego Medical Center, San Diego

02135

St. Elizabeth's Medical Center, Boston

All Listed Sponsors
lead

Corindus Inc.

INDUSTRY

NCT01917682 - Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions | Biotech Hunter | Biotech Hunter